Quest 5-in-1 Dementia Test Focuses on Boomers’ Concerns

Quest 5-in-1 Dementia Test Focuses on Boomers’ Concerns

Emile Wamsteker/Bloomberg

Quest’s stock has dropped 6.2 percent in the past 12 months, compared with a gain of 21 percent for the Standard & Poor’s 500 Health Care Index.